FDA Commissioner Praises TrumpRx as a Major Step Toward Lower Drug Costs
The FDA commissioner praised the Trump administration's plan, TrumpRx, which involves Pfizer offering significant discounts on certain medications through a new government purchasing platform, as a major step toward making prescription drugs more affordable in the US, though experts express skepticism about its overall impact.